scispace - formally typeset
Journal ArticleDOI

Interleukin-6 Modulates Plasma Cholesterol and C-Reactive Protein Concentrations in Nonagenarians

Reads0
Chats0
TLDR
To establish whether the relationship between interleukin‐6 and plasma lipid and C‐reactive protein (CRP) concentrations is different in Finnish nonagenarians than in middle‐aged subjects with lower inflammatory status.
Abstract
OBJECTIVES: To establish whether the relationship between interleukin-6 (IL-6) and plasma lipid and C-reactive protein (CRP) concentrations is different in Finnish nonagenarians than in middle-aged subjects with lower inflammatory status. DESIGN: Cross-sectional. SETTING: Observational cohort study concentrating on the oldest old. PARTICIPANTS: Nonagenarians (n = 291, mean age ± standard deviation 90 ± 1; 68 men, 223 women) who lived in the Tampere municipality in southern Finland and a middle-aged control population from the same area (n = 227, aged 44 ± 8). MEASUREMENTS: Plasma high sensitive CRP and lipid concentrations were analyzed using an automatic analyzer and IL-6 levels using enzyme-linked immunosorbent assay. RESULTS: Plasma concentrations of IL-6 (4.39 ± 5.25 vs 1.88 ± 1.98 pg/mL) and CRP (3.54 ± 4.98 vs 1.53 ± 1.91 mg/L) were significantly higher in nonagenarians than in middle-aged subjects (P<.001). In nonagenarians, plasma CRP levels increased (P<.001) and plasma total cholesterol (P=.006), low-density lipoprotein cholesterol (P=.02), and high-density lipoprotein cholesterol (P=.002) levels decreased according to IL-6 quartiles. In middle-aged subjects, similar associations were not found. CONCLUSION: The relationship between IL-6 and plasma CRP and cholesterol levels in nonagenarians with enhanced systemic inflammation differs from that of middle-aged subjects.

read more

Citations
More filters
Patent

Nanoparticulate megestrol formulations

TL;DR: In this article, the authors proposed a method for nanoparticulate compositions comprising megestrol, which has an effective average particle size of less than about 2000 nm and can be used for particle filtering.
Journal ArticleDOI

Interleukin-1 Receptor Antagonist, Interleukin-6, and C-Reactive Protein as Predictors of Mortality in Nonagenarians: The Vitality 90+ Study

TL;DR: Blood levels of IL-1ra, IL-6, and CRP were higher in persons who died during the follow-up than in those who survived and implicate its role in the complex interaction between inflammatory markers in aging and disease.
Journal ArticleDOI

Inflammatory Markers and Physical Performance Among Nonagenarians

TL;DR: High levels of inflammatory markers and worse handgrip strength as well as a worse Barthel Index result were evident among nonagenarians, however, the association with the chair stand was not significant.
References
More filters
Journal ArticleDOI

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

TL;DR: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.
Journal ArticleDOI

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

TL;DR: The data suggest that the C-reactive protein level is a stronger predictor of cardiovascular events than the LDL cholesterol level and that it adds prognostic information to that conveyed by the Framingham risk score.
Journal ArticleDOI

C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction A Potential Role for Cytokines Originating From Adipose Tissue?

TL;DR: The data suggest that adipose tissue is an important determinant of a low level, chronic inflammatory state as reflected by levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, and that infection with H pylori, C pneumoniae, and cytomegalovirus is not.
Journal ArticleDOI

Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty

TL;DR: It is possible that certain clinically important late-life changes are due to an inappropriate presence of IL-6, and this overview discusses the data relatingIL-6 to age-associated diseases and to frailty.
Related Papers (5)